Real-world efficacy of lutetium peptide receptor radionuclide therapy in patients with neuroendocrine tumors

#3494

Introduction: Lutetium Peptide Receptor Radio Nuclide Therapy (Lu-PRRT) is an effective treatment for progressive, metastatic, somatostatin-receptor-positive, well-differentiated Neuroendocrine Tumors (WD-NETs). It is generally well tolerated.

Aim(s): To report a single centre experience of real-world efficacy and side effects of this treatment.

Materials and methods: The analysis was retrospective. Clinicopathological data were analysed using descriptive statistics, Kaplan-Meier method, and Cox regression.

Conference:

Presenting Author:

Authors: Almeamar H, Cullen L, Murphy D, Crowley R, Skehan S,

Keywords: prrt, neuroendocrine tumor, efficacy, safety,